LTFS
BMY icon

Ladenburg Thalmann Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$20.2M Buy
317,929
+66,641
+27% +$3.82M 0.13% 177
2019
Q3 		$12.7M Buy
251,288
+4,782
+2% +$225K 0.09% 219
2019
Q2 		$11.2M Sell
246,506
-12,166
-5% -$567K 0.08% 237
2019
Q1 		$12.3M Buy
258,672
+33,606
+15% +$1.67M 0.09% 211
2018
Q4 		$11.6M Buy
225,066
+20,920
+10% +$1.12M 0.1% 187
2018
Q3 		$12.7M Buy
204,146
+12,104
+6% +$718K 0.11% 182
2018
Q2 		$12.1M Hold
192,042
– – 0.11% 175
2018
Q1 		$12.1M Sell
192,042
-6,234
-3% -$401K 0.11% 175
2017
Q4 		$12.2M Sell
198,276
-2,378
-1% -$149K 0.12% 170
2017
Q3 		$12.8M Sell
200,654
-13,640
-6% -$796K 0.14% 151
2017
Q2 		$11.9M Sell
214,294
-6,602
-3% -$359K 0.14% 147
2017
Q1 		$12M Sell
220,896
-420
-0.2% -$23K 0.15% 140
2016
Q4 		$12.9M Sell
221,316
-46,423
-17% -$2.54M 0.18% 124
2016
Q3 		$14.4M Buy
267,739
+28,342
+12% +$1.82M 0.22% 108
2016
Q2 		$17.6M Buy
239,397
+27,554
+13% +$1.95M 0.28% 80
2016
Q1 		$13.6M Buy
211,843
+950
+0.5% +$59.9K 0.24% 98
2015
Q4 		$14.5M Sell
210,893
-29,733
-12% -$1.96M 0.27% 88
2015
Q3 		$14.2M Sell
240,626
-35,925
-13% -$2.28M 0.29% 81
2015
Q2 		$18.4M Buy
276,551
+7,362
+3% +$485K 0.34% 68
2015
Q1 		$17.3M Buy
269,189
+53,229
+25% +$3.33M 0.33% 69
2014
Q4 		$12.8M Buy
215,960
+54,363
+34% +$3.07M 0.28% 76
2014
Q3 		$8.27M Sell
161,597
-25,841
-14% -$1.29M 0.23% 97
2014
Q2 		$9.09M Sell
187,438
-45,530
-20% -$2.24M 0.25% 92
2014
Q1 		$12.1M Buy
232,968
+10,079
+5% +$536K 0.35% 64
2013
Q4 		$11.8M Sell
222,889
-2,004
-0.9% -$102K 0.37% 63
2013
Q3 		$10.4M Sell
224,893
-3,092
-1% -$136K 0.35% 65
2013
Q2 		$10.2M Buy
+227,985
New +$9.9M 0.36% 61

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BMY Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Bristol-Myers Squibb (BMY) stake by 27% in Q4 2019, buying an estimated $3.82M and bringing the position to 317,929 shares worth $20.2M. The position accounts for 0.13% of the portfolio, ranked #177.

Ladenburg Thalmann Financial Services first reported a position in BMY in Q2 2013 and has held it in 27 quarters since. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 317,929 shares of Bristol-Myers Squibb worth $20.2M as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 66,641 Bristol-Myers Squibb shares in Q4 2019, an estimated $3.82M.
  • Bristol-Myers Squibb made up 0.13% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #177 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 27 quarters since.
  • 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.